[
  {
    "ts": null,
    "headline": "AstraZeneca's Growth Potential: 6 Reasons For A Buy Rating",
    "summary": "AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the companyâs future looks bright.",
    "url": "https://finnhub.io/api/news?id=b0bffa5a9ae5c47a255e185aa2cf65897e628d26de0c5f6cfe30db3a2a88b556",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737639382,
      "headline": "AstraZeneca's Growth Potential: 6 Reasons For A Buy Rating",
      "id": 132449871,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/107429764/image_107429764.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the companyâs future looks bright.",
      "url": "https://finnhub.io/api/news?id=b0bffa5a9ae5c47a255e185aa2cf65897e628d26de0c5f6cfe30db3a2a88b556"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Completes Acquisition of Nimble Therapeutics",
    "summary": "Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well as a peptide synthesis, screening and optimization platform to strengthen AbbVie's pipeline and R&D...",
    "url": "https://finnhub.io/api/news?id=67a0300771a3870ca07fd3a44c9e6079207279cdc04ed39632ac9325a29d842a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737623886,
      "headline": "AbbVie Completes Acquisition of Nimble Therapeutics",
      "id": 132448711,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well as a peptide synthesis, screening and optimization platform to strengthen AbbVie's pipeline and R&D...",
      "url": "https://finnhub.io/api/news?id=67a0300771a3870ca07fd3a44c9e6079207279cdc04ed39632ac9325a29d842a"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology",
    "summary": "Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platformNeomorph to receive an upfront payment and is eligible...",
    "url": "https://finnhub.io/api/news?id=61dfa8e0f78952a35038b84513cbf1943242f3b82ddd6d4901ab3d40c40aaf44",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737622871,
      "headline": "AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology",
      "id": 132448565,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platformNeomorph to receive an upfront payment and is eligible...",
      "url": "https://finnhub.io/api/news?id=61dfa8e0f78952a35038b84513cbf1943242f3b82ddd6d4901ab3d40c40aaf44"
    }
  },
  {
    "ts": null,
    "headline": "How To Invest $100,000 In The Ten Cheapest Dow Dividend 100 Stocks",
    "summary": "SCHD is one of my favorite dividend funds. Check out the Top 20 holdings of SCHD and score them according to which, I believe, are the top 10 cheapest of the lot.",
    "url": "https://finnhub.io/api/news?id=7986981a49e059c451440c17aa615ffa1b9d38e9d37b2b0a7a28b252e7b8ab60",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737605869,
      "headline": "How To Invest $100,000 In The Ten Cheapest Dow Dividend 100 Stocks",
      "id": 132447070,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "SCHD is one of my favorite dividend funds. Check out the Top 20 holdings of SCHD and score them according to which, I believe, are the top 10 cheapest of the lot.",
      "url": "https://finnhub.io/api/news?id=7986981a49e059c451440c17aa615ffa1b9d38e9d37b2b0a7a28b252e7b8ab60"
    }
  }
]